SCHEMBL25946134

SCHEMBL25946134

CNc1cncn(Cc2cc3cc(F)cc(CCC(F)(F)F)c3n2C(=O)OC(C)(C)C)c1=O

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21703068 0.88 MAP4K1 (0.59) MAP4K1
SCHEMBL30203276 0.80 MAP4K1 (1.00) MAP4K1
SCHEMBL21703306 0.80 MAP4K1 (1.00) MAP4K1
SCHEMBL21703305 0.80 MAP4K1 (1.00) MAP4K1
SCHEMBL30203335 0.80 MAP4K1 (1.00) MAP4K1
SCHEMBL21703069 0.78 MAP4K1 (0.51) MAP4K1
SCHEMBL21685476 0.78 MAP4K1 (0.58) MAP4K1
SCHEMBL21703070 0.78 MAP4K1 (0.57) MAP4K1
SCHEMBL21685064 0.77 MAP4K1 (0.46) MAP4K1
SCHEMBL21685063 0.76 MAP4K1 (0.45) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 EP disclosed